Results 11 to 20 of about 46,768 (219)

Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review

open access: yesSubstance Abuse and Rehabilitation, 2017
Christa R Lewis,1,2 Hoa T Vo,1 Marc Fishman1,3 1Maryland Treatment Centers, Baltimore, MD, USA; 2Department of Psychology, Towson University, Towson, MD, USA; 3Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD, USA Abstract ...
Lewis CR, Vo HT, Fishman M
doaj   +1 more source

Effect of physical exercise on pain thresholds and plasma beta-endorphins in patients with silent and symptomatic myocardial ischaemia [PDF]

open access: yes, 1988
In a double-blind study, eight patients with symptomatic myocardial ischaemia and nine with asymptomatic myocardial ischaemia were compared during physical exercise under naloxone (6 mg i.v.) or placebo. Plasma beta-endorphin, cortisol and catecholamines
Roskamm, H.   +3 more
core   +1 more source

Practices and concerns related to naloxone use among emergency medical service providers in a rural state: A mixed-method examination

open access: yesPreventive Medicine Reports, 2019
The rate of opioid misuse and overdose continues to increase in rural areas of the U.S. In response, access to naloxone hydrochloride (“naloxone”), an opioid antagonist used to reverse opioid overdose, has increased among both first responders and ...
Tess M. Kilwein   +3 more
doaj   +1 more source

Effectiveness of an Advanced Naloxone Training, Simulation, and Assessment of Second-Year Pharmacy Students

open access: yesPharmacy, 2022
Background: Opioid overdoses continue to be one of the most urgent public health priorities. In 2020, reported overdose deaths in the United States reached a high of over 93,000 cases. As the COVID-19 pandemic and opioid crisis continues to be addressed,
Jennifer Courtney   +6 more
doaj   +1 more source

Expert views on state-level naloxone access laws: a qualitative analysis of an online modified-Delphi process

open access: yesHarm Reduction Journal, 2022
Background Expanding availability to naloxone is a core harm reduction strategy in efforts to address the opioid epidemic. In the US, state-level legislation is a prominent mechanism to expand naloxone availability through various venues, such as ...
Sean Grant, Rosanna Smart
doaj   +1 more source

Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study

open access: yesThe Lancet Public Health, 2022
Summary: Background: The US overdose crisis is driven by fentanyl, heroin, and prescription opioids. One evidence-based policy response has been to broaden naloxone distribution, but how much naloxone a community would need to reduce the incidence of ...
Michael A Irvine, PhD   +10 more
doaj   +1 more source

Prehospital naloxone administration – what influences choice of dose and route of administration?

open access: yesBMC Emergency Medicine, 2020
Background Amidst the ongoing opioid crisis there are debates regarding the optimal route of administration and dosages of naloxone. This applies both for lay people administration and emergency medical services, and in the development of new naloxone ...
Ida Tylleskar   +6 more
doaj   +1 more source

Should we be routinely co-prescribing naloxone for patients on long term opioids?

open access: yes, 2021
Community naloxone supply to prevent fatal overdose needs to consider patients using pharmaceutical ...
Nielsen, Suzanne, Prathivadi, Pallavi
core   +1 more source

Randomised Trial of Intranasal Versus Intramuscular Naloxone in Prehospital Treatment for Suspected Opioid Overdose

open access: yes, 2005
Objective: To determine the effectiveness of intranasal (IN) naloxone compared with intramuscular (IM) naloxone for treatment of respiratory depression due to suspected opiate overdose in the prehospital setting.
Kelly, Anne-Maree   +5 more
core   +3 more sources

Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study

open access: yesHarm Reduction Journal, 2006
Background Drug-induced and drug-related deaths have been increasing for the past decade throughout the US. In NYC, drug overdose accounts for nearly 900 deaths per year, a figure that exceeds the number of deaths each year from homicide.
Galea Sandro   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy